Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.36 |
| ▸ | TSHR | P16473 | 7/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20768403 | 0.77 | PHGDH (0.52) | CYP2D6ALDH1A1SLC6A9CYP3A4TSHR | |
| SCHEMBL19331205 | 0.71 | SLC6A9 (0.37) | ALDH1A1SLC6A9GAA | |
| SCHEMBL31559331 | 0.70 | CYP2D6 (0.44) | CYP2D6ALDH1A1SLC6A9CYP3A4TSHR | |
| SCHEMBL19331213 | 0.68 | SLC6A9 (0.37) | SLC6A9 | |
| SCHEMBL19331368 | 0.68 | OPRD1 (0.42) | TSHRKDM4E | |
| SCHEMBL19330891 | 0.68 | SLC6A9 (0.34) | SLC6A9 | |
| SCHEMBL19331329 | 0.66 | PHGDH (0.42) | PTGS2 | |
| SCHEMBL19330953 | 0.66 | PHGDH (0.41) | — | |
| SCHEMBL19331214 | 0.66 | SLC6A9 (0.37) | ALDH1A1SLC6A9TSHRHSD17B10KDM4E | |
| SCHEMBL19330885 | 0.65 | POLB (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3426243-A1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | Raze Therapeutics Inc. (US) | 2019-01-16 | — | — | EP | disclosed |
| WO-2017156165-A1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | RAZE THERAPEUTICS, INC. (US) | 2017-09-14 | — | — | WO | disclosed |